Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
Jean–Frédéric Colombel(Centre Hospitalier Universitaire de Lille), William J. Sandborn(WinnMed), Paul Rutgeerts(KU Leuven), Robert Enns(St. Paul's Hospital), Stephen B. Hanauer(University of Chicago), Remo Panaccione(University of Calgary), Stefan Schreiber(Christian-Albrechts-Universität zu Kiel), Dan Byczkowski, Ju Li(Abbott Fund), Jeffrey D. Kent, Paul F. Pollack
Cited by 2,244
Abstract
Related Papers
No related papers found
Powered by citation graph analysis